Navigation Links
‘Baby Food’ to Battle Obesiy

In the war against the lard, a new weapon is being investigated.//

Scientists have reported plans to test out a baby food ingredient -oligo fructose, on obese human subjects.

The move follows an earlier study that showed the natural fiber seen in baby foods, cereals and yogurt had a positive effect on genetically obese lab rats.

Reportedly, oligo fructose increased the amounts of a hormone named GLP-1; glucagon like peptide that was responsible for a feeling of satiety. The fiber also had a stimulating effect on the gene that was responsible for this hormone. In retrospect the rats under observation ate less and had a better blood lipid profile.

Says Dr. Raylene Reimer of University of Calgary, Faculty of Kinesiology who led the research “It may not be the magic bullet but in all likelihood this will likely be one factor that people can change in their life to help achieve a healthy body weight. It won't cure obesity or cause people to drop half their body weight -- not even our strongest obesity drugs can do that -- but we believe it could help."

In the human trial Reimer and team will test the effect on 50 overweight but otherwise healthy persons who will be asked to take a dietary supplement along with their diet over a three-month period.
ANN
'"/>




Page: 1

Related medicine news :

1. Baby Gloom: ‘Baby Gap’ Generation Signals Babies’ Days Ot!
2. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
3. Firefighters Continue To Battle Blaze
4. Countries Step up Battle Against Bird Flu
5. Kylies Personal Battle Against Breast Cancer May Soon Come To An End
6. Breakthrough in Battle Against Cancer
7. Women Win Legal Battle Over Treatment Of Breast Cancer
8. Pramod Mahajan Continues to Battle for His Life
9. 240 Hours And Counting As Mahajan Continues To Battle For Life
10. Parents Battle Put 8-Year Old Boy In Trouble
11. Little Makoda-Poster Girl For Leukemia Awareness Campaign Losses Her Battle Of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: